Stockscreener 앱 받기
2.43%
시장 영업 전:
Amgen Inc 주식(AMGN)의 최신 뉴스
New York State Teachers Retirement System Sells 9,158 Shares of Amgen Inc. $AMGN - MarketBeat
BofA Securities raises Amgen stock price target on growth drivers By Investing.com - Investing.com Canada
Amgen: The Quarter Where New Growth Engines Begin to Drown Out the Noise of Patent Expirations - marketscreener.com
Strategic Blueprint LLC Lowers Position in Amgen Inc. $AMGN - MarketBeat
Danske Bank A S Decreases Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Fifth Third Bancorp - MarketBeat
Amgen Inc (AMGN) Q1 2026 Earnings Call Highlights: Strong Product Sales Growth Amidst Competitive Challenges - GuruFocus
AMGN Q1 Deep Dive: Growth Drivers Offset Patent Losses, Pipeline Progress in Focus - The Globe and Mail
Amgen (NASDAQ:AMGN) Issues Quarterly Earnings Results - MarketBeat
Amgen : C O R R E C T I O N Amgen/ - marketscreener.com
Amgen Doubles Down On Less Frequent MariTide Maintenance Dosing In Obesity - Citeline News & Insights
Amgen (AMGN) Q1 Earnings Exceed Expectations with Strong Revenue Growth - GuruFocus
Sixteen Amgen drugs posted double-digit sales growth in Q1 - Stock Titan
/C O R R E C T I O N -- Amgen/ - Yahoo Finance
Amgen (AMGN) Q1 2026 Earnings Transcript - AOL.com
Amgen (AMGN) Increases Revenue Projections for FY26 - GuruFocus
Amgen Q1 2026 slides: 16 brands fuel growth despite patent headwinds - Investing.com
Amgen Tops Estimates Despite Mixed Performance of Key Drugs - Bloomberg.com
Amgen Q1 Earnings Call Highlights - MarketBeat
Amgen (AMGN) Reports Strong Q1 Revenue Performance - GuruFocus
Amgen (AMGN) Adjusts Revenue Projections for FY26 Upwards - GuruFocus
Earnings call transcript: Amgen Q1 2026 beats expectations, raises guidance - Investing.com
Amgen sales rise 4% in first quarter, broadens weight-loss drug development - KFGO
Earnings call transcript: Amgen Q1 2026 beats expectations, raises guidance By Investing.com - Investing.com Canada
Amgen achieves Q1 double beat; 2026 guidance ranges meet expectations - Seeking Alpha
Transcript: Amgen Q1 2026 Earnings Conference Call - Benzinga
Amgen (AMGN) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Amgen Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:AMGN) 2026-04-30 - Seeking Alpha
Highlights from Amgen's 2026 First Quarter Earnings Report - Amgen
Amgen beats Q1 earnings and revenue estimates, but shares dip as R&D spend rises - Investing.com Nigeria
FDA Approval for PAVBLU issued to AMGEN INC - Quantisnow
Amgen (NASDAQ:AMGN) Releases FY 2026 Earnings Guidance - MarketBeat
Regeneron Presses Amgen for Eylea Antitrust Damages Evidence - Bloomberg Law News
Amgen’s (NASDAQ:AMGN) Q1 CY2026 Sales Top Estimates - The Globe and Mail
Amgen Posts Higher First-Quarter Profit, Revenue - WSJ
Amgen Q1 Adjusted Earnings, Revenue Rise - marketscreener.com
Earnings Flash (AMGN) Amgen Inc. Reports Q1 Revenue $8.62B, vs. FactSet Est of $8.58B - marketscreener.com
(AMGN) Amgen Expects 2026 Adjusted EPS Range $21.70-$23.10, vs. FactSet Est of $22.16 - marketscreener.com
Earnings Flash (AMGN) Amgen Inc. Posts Q1 Adjusted EPS $5.15 per Share, vs. FactSet Est of $4.77 - marketscreener.com
(AMGN) Amgen Expects 2026 Revenue Range $37.1B-$38.5B, vs. FactSet Est of $37.81B - marketscreener.com
Amgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug - Reuters
[8-K] AMGEN INC Reports Material Event - Stock Titan
AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS - marketscreener.com
Amgen's Q1 revenue at $8.6B, slightly above estimates - Breakingthenews.net
Amgen Inc Stock (AMGN) Moved Up by 3.25% on Apr 30: Key Drivers Unveiled - TradingKey
Caterpillar, Amgen Share Gains Lead Dow's 729-Point Rally - Moomoo
State of New Jersey Common Pension Fund D Has $60.22 Million Holdings in Amgen Inc. $AMGN - MarketBeat
US Bancorp DE Lowers Stock Holdings in Amgen Inc. $AMGN - MarketBeat
What Are Wall Street Analysts' Target Price for Amgen Stock? - Barchart.com
GC Wealth Management RIA LLC Reduces Stock Position in Amgen Inc. $AMGN - MarketBeat
Is Amgen Stock Undervalued Stock Or Value Trap? - Trefis
Amgen Inc. Stock (US0311621009): Morgan Stanley Raises Price Target to $326 - AD HOC NEWS
Amgen Inc. Stock (US0311621009): Reports Strong Q1 2026 Results with Revenue Beat - AD HOC NEWS
FDA Tavneos Proposal Puts Amgen Trial Integrity And Growth Story Under Review - simplywall.st
Q1 2026 results announcement sees Amgen stock trade slightly down - Traders Union
Vanguard reports 7.51% stake in Amgen (NASDAQ: AMGN) via Schedule 13G - Stock Titan
FDA review panel challenges Amgen's Tavneos approval on efficacy, data grounds - MSN
Amgen Inc. $AMGN Shares Purchased by Vest Financial LLC - MarketBeat
Earnings To Watch: Amgen (AMGN) Reports Q1 Results Tomorrow - Yahoo Finance
Amgen Inc. $AMGN Shares Purchased by Keybank National Association OH - MarketBeat
How Will Amgen Stock React To Its Upcoming Earnings? - Trefis
Understanding Momentum Shifts in (AMGN) - Stock Traders Daily
US FDA Details Data Manipulation, False Statements In Tavneos Withdrawal Request - Citeline News & Insights
Amgen (AMGN) and AstraZeneca (AZN) Launch Real-Time Clinical Tri - GuruFocus
Paradigm Health collaborates with FDA to transform regulatory review of clinical trial data - marketscreener.com
Amgen, Astra launch real-time trials as FDA to expedite drug development using AI - Seeking Alpha
Feds allege that Bay Area company manipulated results of study that led to multibillion-dollar buyout - The Business Journals
FDA Review Panel Challenges Amgen's Tavneos Approval On Efficacy, Data Grounds - Benzinga
4.79%
1.60%
자본화:
|
볼륨(24시간):